SJ Medical
SJ Medical
The global Intravascular Ultrasound (IVUS) system market is witnessing a paradigm shift as interventional cardiology moves from traditional angiography-guided procedures to precision imaging-guided interventions. IVUS, a medical imaging methodology using a specialized catheter with a miniaturized ultrasound probe, provides a unique 360-degree view from inside the blood vessel. This allows clinicians to see the vessel wall, plaque volume, and lumen size with unparalleled clarity.
Top suppliers and exporters are now focusing on high-definition (HD) IVUS systems that offer frequencies up to 60MHz, providing superior resolution for complex PCI (Percutaneous Coronary Intervention) cases. These systems are no longer just luxury tools in high-end Western hospitals; they are becoming essential standards of care in emerging markets across Asia, Latin America, and the Middle East.
Artificial Intelligence is revolutionizing IVUS by automating plaque characterization and vessel measurement. This reduces operator dependency and speeds up procedural workflows in the Cath Lab.
The integration of IVUS with Optical Coherence Tomography (OCT) on a single catheter is a burgeoning trend, offering both deep penetration (IVUS) and high surface resolution (OCT) simultaneously.
Developing smaller, more flexible catheters (down to 2.5F) allows for the imaging of increasingly distal and tortuous vessels, expanding the clinical application of IVUS to peripheral and neurovascular interventions.
When global hospitals and medical distributors source IVUS systems, they prioritize three core pillars: Reliability, Resolution, and Cost-effectiveness. In high-volume cardiac centers, the speed of catheter "pullback" and the ease of software interface are critical. In contrast, in developing regions, the "Total Cost of Ownership" (including disposable catheter costs) is the primary driver for procurement.
As a specialized manufacturer based in Hangzhou, China, Hangzhou SJ Medical Co., Ltd. bridges the gap between high-end innovation and market accessibility. Our advantage lies in our 5,000sqm GMP-compliant facility and a rigorous quality control system that rivals global leaders.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems. Through continuous innovation and strong R&D capabilities, the company has obtained multiple patents and international certifications, laying a solid foundation for sustainable growth in both domestic and global markets.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop.
Equipped with advanced production systems, including precision balloon forming, laser welding, and marking technologies. These capabilities ensure high levels of manufacturing accuracy and product consistency.
Strictly adhering to international quality standards, we have obtained CE certification, ISO 13485 quality management system certification, and CFDA approval.
SJ Medical has established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Its products are currently distributed in countries such as Finland, Italy, Spain, France, the Netherlands, India, Indonesia, Turkey, and Egypt. We offer comprehensive OEM/ODM services for global partners looking to expand their vascular intervention portfolio.
The rise of China as a hub for medical device manufacturing is not just about cost—it's about the vertical integration of the supply chain and rapid R&D cycles. For an Intravascular Ultrasound System, this means:
By choosing a top exporter from China, global buyers gain access to world-class technology at a value proposition that allows for broader patient access to life-saving interventional procedures.
